Intracellular hypoxia measured by (18)F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer

BACKGROUND: Hypoxia is a key driver of cancer progression. We evaluated the prognostic impact of (18)F-fluoromisonidazole (FMISO) prior to treatment in patients with breast cancer. METHODS: Forty-four patients with stage II/III primary breast cancer underwent positron emission tomography/computed wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast Cancer Res
Hauptverfasser: Asano, Aya, Ueda, Shigeto, Kuji, Ichiei, Yamane, Tomohiko, Takeuchi, Hideki, Hirokawa, Eiko, Sugitani, Ikuko, Shimada, Hiroko, Hasebe, Takahiro, Osaki, Akihiko, Saeki, Toshiaki
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2018
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6063018/
https://ncbi.nlm.nih.gov/pubmed/30053906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-018-0970-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge